JP2024527742A5 - - Google Patents
Info
- Publication number
- JP2024527742A5 JP2024527742A5 JP2024501135A JP2024501135A JP2024527742A5 JP 2024527742 A5 JP2024527742 A5 JP 2024527742A5 JP 2024501135 A JP2024501135 A JP 2024501135A JP 2024501135 A JP2024501135 A JP 2024501135A JP 2024527742 A5 JP2024527742 A5 JP 2024527742A5
- Authority
- JP
- Japan
- Prior art keywords
- intrathecal
- approximately
- meters
- composition according
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163229936P | 2021-08-05 | 2021-08-05 | |
| US63/229,936 | 2021-08-05 | ||
| US202163239881P | 2021-09-01 | 2021-09-01 | |
| US63/239,881 | 2021-09-01 | ||
| PCT/US2022/074622 WO2023015304A1 (en) | 2021-08-05 | 2022-08-05 | Adeno-associated virus particles and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024527742A JP2024527742A (ja) | 2024-07-26 |
| JP2024527742A5 true JP2024527742A5 (cg-RX-API-DMAC7.html) | 2025-08-14 |
Family
ID=85156338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024501135A Pending JP2024527742A (ja) | 2021-08-05 | 2022-08-05 | アデノ随伴ウイルス粒子及びその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250041450A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4380626A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024527742A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240045203A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022325165A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3224482A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024001634A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023015304A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202613313A (zh) | 2024-05-31 | 2026-04-01 | 美商薩羅塔治療公司 | 肌向性raav |
| CN119144658A (zh) * | 2024-09-13 | 2024-12-17 | 南京鼓楼医院 | 一种调控平滑肌收缩的aav载体及其构建方法和应用 |
| WO2026094009A1 (en) * | 2024-11-04 | 2026-05-07 | Insmed Incorporated | Compositions and methods for treating duchenne muscular dystrophy |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1366160B1 (en) * | 2000-10-06 | 2008-07-09 | The Regents Of The University Of Michigan | Mini-dystrophin nucleic acid and peptide sequences |
| US9624282B2 (en) * | 2012-11-26 | 2017-04-18 | The Curators Of The University Of Missouri | Microdystrophin peptides and methods for treating muscular dystrophy using the same |
| US9850497B2 (en) * | 2013-11-04 | 2017-12-26 | Regents Of The University Of Minnesota | Gene targeting methods and tools |
| AU2015208247B2 (en) * | 2014-01-21 | 2021-05-27 | Universiteit Gent | Muscle-specific nucleic acid regulatory elements and methods and use thereof |
| CA2971303C (en) * | 2016-06-21 | 2026-03-03 | Bamboo Therapeutics, Inc. | Optimized mini-dystrophin genes and expression cassettes and their use |
| CN110997923B (zh) * | 2017-03-17 | 2024-01-02 | 全国儿童医院研究所 | 腺相关病毒载体递送肌肉特异性微肌营养不良蛋白以治疗肌营养不良症 |
| CA3063464A1 (en) * | 2017-05-19 | 2018-11-22 | Encoded Therapeutics, Inc. | High activity regulatory elements |
| US20200405824A1 (en) * | 2019-06-26 | 2020-12-31 | University Of Washington | Use of ribonucleotide reductase alone or in combination with micro-dystrophin to treat duchenne muscular dystrophy striated muscle disease |
| WO2020261178A1 (en) * | 2019-06-27 | 2020-12-30 | Pfizer Inc. | Methods of treating duchenne muscular dystrophy using aav mini-dystrophin gene therapy |
| JP2022551986A (ja) * | 2019-10-16 | 2022-12-14 | ザ・ブロード・インスティテュート・インコーポレイテッド | 修飾筋肉標的化組成物 |
| US20230040544A1 (en) * | 2019-12-16 | 2023-02-09 | Research Institute At Nationwide Children's Hospital | Compositions and methods for restoring and maintaining the dystrophin-associated protein complex (dapc) |
| WO2022029543A1 (en) * | 2020-08-06 | 2022-02-10 | Intas Pharmaceuticals Ltd. | Adeno-associated virus vector delivery of micro-dystrophin to treat muscular dystrophy |
| KR20250099412A (ko) * | 2020-11-12 | 2025-07-01 | 프리시젼 바이오사이언시스 인코포레이티드 | 디스트로핀 유전자 내의 인식 서열에 대해 특이성을 갖는 조작된 메가뉴클레아제 |
-
2022
- 2022-08-05 WO PCT/US2022/074622 patent/WO2023015304A1/en not_active Ceased
- 2022-08-05 US US18/294,792 patent/US20250041450A1/en active Pending
- 2022-08-05 KR KR1020247002648A patent/KR20240045203A/ko active Pending
- 2022-08-05 CA CA3224482A patent/CA3224482A1/en active Pending
- 2022-08-05 EP EP22854128.0A patent/EP4380626A4/en active Pending
- 2022-08-05 MX MX2024001634A patent/MX2024001634A/es unknown
- 2022-08-05 JP JP2024501135A patent/JP2024527742A/ja active Pending
- 2022-08-05 AU AU2022325165A patent/AU2022325165A1/en active Pending